| Primary |
| Hypertension |
67.3% |
| Drug Use For Unknown Indication |
12.9% |
| Atrial Fibrillation |
4.0% |
| Blood Pressure |
3.0% |
| Vasospasm |
3.0% |
| Product Used For Unknown Indication |
2.0% |
| Anticoagulant Therapy |
1.0% |
| Arrhythmia |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Heart Rate Irregular |
1.0% |
| Pulmonary Hypertension |
1.0% |
| Raynaud's Phenomenon |
1.0% |
| Respiratory Tract Infection |
1.0% |
| Ventricular Tachycardia |
1.0% |
|
| Bradycardia |
13.6% |
| Nausea |
11.9% |
| Tachycardia |
6.8% |
| Transient Ischaemic Attack |
6.8% |
| Musculoskeletal Chest Pain |
5.1% |
| Myocardial Ischaemia |
5.1% |
| Neck Pain |
5.1% |
| Oedema Peripheral |
5.1% |
| Blood Sodium Decreased |
3.4% |
| Cardiac Arrest |
3.4% |
| Death |
3.4% |
| Fatigue |
3.4% |
| Heart Rate Decreased |
3.4% |
| Hypersensitivity |
3.4% |
| Nervousness |
3.4% |
| Palpitations |
3.4% |
| Poor Quality Drug Administered |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Toe Amputation |
3.4% |
| Urticaria |
3.4% |
|
| Secondary |
| Hypertension |
34.8% |
| Product Used For Unknown Indication |
22.4% |
| Drug Use For Unknown Indication |
13.7% |
| Atrial Fibrillation |
6.2% |
| Ill-defined Disorder |
3.7% |
| Vasospasm |
3.7% |
| Anxiety |
2.5% |
| Colitis |
2.5% |
| Blood Pressure |
1.2% |
| Cardiovascular Disorder |
1.2% |
| Cerebrovascular Accident Prophylaxis |
1.2% |
| Essential Hypertension |
1.2% |
| Pain |
1.2% |
| Actinic Keratosis |
0.6% |
| Arrhythmia |
0.6% |
| Blood Cholesterol |
0.6% |
| Cardiac Failure Congestive |
0.6% |
| Depression |
0.6% |
| Diarrhoea |
0.6% |
| Fluid Retention |
0.6% |
|
| Palpitations |
10.8% |
| Muscle Disorder |
8.1% |
| Atrial Fibrillation |
5.4% |
| Bradycardia |
5.4% |
| Drug Hypersensitivity |
5.4% |
| Drug Ineffective |
5.4% |
| Drug Interaction |
5.4% |
| Nausea |
5.4% |
| Transient Ischaemic Attack |
5.4% |
| Tremor |
5.4% |
| Vision Blurred |
5.4% |
| Weight Decreased |
5.4% |
| Weight Increased |
5.4% |
| Xanthopsia |
5.4% |
| Abdominal Pain Upper |
2.7% |
| Disorientation |
2.7% |
| Drug Administered At Inappropriate Site |
2.7% |
| Dyspepsia |
2.7% |
| Hepatic Enzyme Increased |
2.7% |
| Hypersensitivity |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.8% |
| Hypertension |
14.3% |
| Drug Use For Unknown Indication |
7.7% |
| Asthma |
4.7% |
| Depression |
4.2% |
| Blood Cholesterol Increased |
3.5% |
| Diabetes Mellitus |
3.5% |
| Pain |
3.4% |
| Osteoporosis |
3.3% |
| Cardiac Disorder |
3.1% |
| Arthritis |
3.0% |
| Hormone Replacement Therapy |
3.0% |
| Atrial Fibrillation |
2.8% |
| Anxiety |
2.7% |
| Rheumatoid Arthritis |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Smoking Cessation Therapy |
2.4% |
| Prophylaxis |
2.3% |
| Osteoarthritis |
2.0% |
| Blood Pressure |
2.0% |
|
| Weight Increased |
8.2% |
| Death |
7.2% |
| Myocardial Infarction |
7.2% |
| Wheezing |
7.2% |
| Nausea |
6.5% |
| Vomiting |
6.5% |
| Viral Infection |
5.8% |
| Pneumonia |
5.1% |
| Tremor |
5.1% |
| Weight Decreased |
5.1% |
| Transient Ischaemic Attack |
4.5% |
| Vision Blurred |
4.5% |
| Somnolence |
4.1% |
| Tooth Infection |
4.1% |
| Pain In Extremity |
3.4% |
| Pruritus |
3.4% |
| Breast Cancer Female |
3.1% |
| Oedema Peripheral |
3.1% |
| Renal Failure |
3.1% |
| Cardiac Failure Congestive |
2.7% |
|
